Innate Pharma S.A. (IPHA)
Nasdaq • IPHA • US45781K2042
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 0.2% of free float sold short, 3.1 days to cover, cost to borrow 5.79%. Sign up for live short interest data.
Market Cap
132m USD | # 8036 in US
Volume
160.79k shares | 289.86k USD
Shares Outstanding
93.7m
Free Float Shares
76.85% | 72.01m
